Cibc Private Wealth Group, LLC Xenon Pharmaceuticals Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 39 shares of XENE stock, worth $1,603. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39Holding current value
$1,603% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XENE
# of Institutions
224Shares Held
73.2MCall Options Held
336KPut Options Held
309K-
Avoro Capital Advisors LLC New York, NY5.4MShares$222 Million3.08% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.34MShares$178 Million1.31% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$148 Million6.91% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$147 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$131 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.56B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...